Clinical Trial Update: Efficacy and Safety of DF289 Plus DF277 Otic Solution in the Treatment of Middle Ear Infections in Pediatric Patients [Phase 3]

View source ↗

Summary

Phase 3 trial assessing efficacy and safety of DF289 plus DF277 otic solution for pediatric acute otitis media has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Otitis Media

Drugs mentioned

• DF289 Plus DF277 Otic Solution

Snippet

Sponsor: Salvat | Conditions: Acute Otitis Media | Phase 3 | Status: COMPLETED | Results posted: 2015-11-23